Non-allergist healthcare workers views on delivering a penicillin allergy de-labelling inpatient pathway: identifying the barriers and enablers
dc.contributor.author | Powell, N | |
dc.contributor.author | Upton, M | |
dc.contributor.author | Kent, B | |
dc.contributor.author | Sandoe, J | |
dc.contributor.author | Tonkin-Crine, S | |
dc.date.accessioned | 2024-02-09T02:05:54Z | |
dc.date.available | 2024-02-09T02:05:54Z | |
dc.date.issued | 2023-12-28 | |
dc.identifier.issn | 2632-1823 | |
dc.identifier.issn | 2632-1823 | |
dc.identifier.other | ARTN dlae014 | |
dc.identifier.uri | https://pearl.plymouth.ac.uk/handle/10026.1/22039 | |
dc.description.abstract |
Background Non-allergist delivered PADL is supported by UK and World Health Organization guidelines but is not yet routine in UK hospitals. Understanding the views of healthcare workers (HCWs) on managing patients with penA records and exploring perspectives on delivering a PADL inpatient pathway are required to inform the development of non-allergist delivered PADL pathways. Objective To explore the perspectives of non-allergist HCWs working in medical specialties on managing patients with penA records, and to explore the enablers and barriers to embedding PADL as a standard of care for inpatients. Methods Semi-structured interviews with doctors, nurses, pharmacists and medicines optimization pharmacy technicians working in a district general hospital in the UK. Thematic analysis was used to analyse the data. Results The PADL pathway was considered a shared responsibility of the multidisciplinary team, which needed to be structured and supported by a framework. PADL aligns with HCW roles but time to deliver PADL was a barrier. Training for HCWs on the benefits of PADL and delivering PADL for those patients where a penicillin might be beneficial during the current episode of care would both motivate HCWs to deliver PADL. Discussion and conclusion The PADL pathway was acceptable to HCWs and aligned with their roles and current healthcare processes but their capacity to deliver PADL in a time pressured environment was a significant barrier. | |
dc.format.extent | dlae014- | |
dc.format.medium | Electronic-eCollection | |
dc.language | en | |
dc.publisher | Oxford University Press (OUP) | |
dc.subject | 3214 Pharmacology and Pharmaceutical Sciences | |
dc.subject | 3207 Medical Microbiology | |
dc.subject | 32 Biomedical and Clinical Sciences | |
dc.subject | 3202 Clinical Sciences | |
dc.subject | Health Services | |
dc.subject | Clinical Research | |
dc.subject | 8.1 Organisation and delivery of services | |
dc.subject | 8 Health and social care services research | |
dc.subject | 3 Good Health and Well Being | |
dc.title | Non-allergist healthcare workers views on delivering a penicillin allergy de-labelling inpatient pathway: identifying the barriers and enablers | |
dc.type | journal-article | |
dc.type | Article | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/38328264 | |
plymouth.issue | 1 | |
plymouth.volume | 6 | |
plymouth.publisher-url | http://dx.doi.org/10.1093/jacamr/dlae014 | |
plymouth.publication-status | Published | |
plymouth.journal | JAC-Antimicrobial Resistance | |
dc.identifier.doi | 10.1093/jacamr/dlae014 | |
plymouth.organisational-group | |Plymouth | |
plymouth.organisational-group | |Plymouth|Research Groups | |
plymouth.organisational-group | |Plymouth|Faculty of Health | |
plymouth.organisational-group | |Plymouth|Faculty of Health|School of Nursing and Midwifery | |
plymouth.organisational-group | |Plymouth|Research Groups|Institute of Health and Community | |
plymouth.organisational-group | |Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | |Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CBR | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA | |
plymouth.organisational-group | |Plymouth|Users by role | |
plymouth.organisational-group | |Plymouth|Users by role|Academics | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA|UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
plymouth.organisational-group | |Plymouth|Faculty of Health|School of Biomedical Sciences | |
plymouth.organisational-group | |Plymouth|Users by role|Researchers in ResearchFish submission | |
plymouth.organisational-group | |Plymouth|Research Groups|Plymouth Institute of Health and Care Research (PIHR) | |
plymouth.organisational-group | |Plymouth|REF 2028 Researchers by UoA | |
plymouth.organisational-group | |Plymouth|REF 2028 Researchers by UoA|UoA01 Clinical Medicine | |
plymouth.organisational-group | |Plymouth|REF 2028 Researchers by UoA|UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2024-01-15 | |
dc.date.updated | 2024-02-09T02:05:54Z | |
dc.rights.embargodate | 2024-2-10 | |
dc.identifier.eissn | 2632-1823 | |
rioxxterms.versionofrecord | 10.1093/jacamr/dlae014 |